Abstract NG01: Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer-Reference-Cited by-同舟云学术

Abstract NG01: Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer

Published:2017-07-01 Issue: Volume: Page:
ISSN:
Container-title:Immunology
language:
Short-container-title:

Author:

Anagnostou Valsamo,Smith Kellie N.,Forde Patrick M.,Niknafs Noushin,Bhattacharya Rohit,White James,Adleff Vilmos,Phallen Jillian,Wali Neha,Hruban Carolyn,Guthrie Violeta B.,Rodgers Kristen,Naidoo Jarushka,Kang Hyunseok,Sharfman William,Georgiades Christos,Verde Franco,Illei Peter,Li Qing Ka,Gabrielson Edward,Brock Malcolm,Zahnow Cynthia,Baylin Stephen B.,Scharpf Rob,Brahmer Julie R.,Karchin Rachel,Pardoll Drew M.,Velculescu Victor E.

Publisher

American Association for Cancer Research

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation of cancer vaccine immunogens derived from Oncofetal antigen (OFA/iLRP) using variable epitope libraries tested in an aggressive breast cancer model;Molecular Immunology;2021-11

2. Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies;Journal for ImmunoTherapy of Cancer;2021-10

3. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery;Frontiers in Immunology;2021-07-15

4. The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy;Frontiers in Oncology;2021-06-29

5. Durable Response to Immunotherapy With Antiangiogenic Drug in Large-Cell Lung Carcinoma With Multiple Fulminant Postoperative Metastases: A Case Report;Frontiers in Oncology;2021-05-20